John Trizzino
President at NOVAVAX, INC.
Net worth: 133 706 $ as of 2024-03-30
Profile
Mr. John J. Trizzino is a CFO, EVP, Chief Commercial & Business Officer at Novavax, Inc. Mr. Trizzino was previously employed as a Chief Executive Officer & Director by ImmunoVaccine, Inc., a Vice President-Vaccine Franchise by MedImmune LLC, a Vice President-Business Development by ID Biomedical Corp., and a Vice President-Business Development by Henry Schein, Inc. He also served on the board at Tech Council of Maryland, Inc. He received his undergraduate degree from Long Island University and an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVAVAX, INC.
0.02% | 2024-03-09 | 27,972 ( 0.02% ) | 133 706 $ | 2024-03-30 |
John Trizzino active positions
| Companies | Position | Start |
|---|---|---|
| NOVAVAX, INC. | President | 2023-11-19 |
Former positions of John Trizzino
| Companies | Position | End |
|---|---|---|
| IMV INC. | Chief Executive Officer | 2013-08-31 |
| NOVAVAX, INC. | Corporate Officer/Principal | 2011-09-05 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 2008-12-31 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 2008-12-31 |
| HENRY SCHEIN, INC. | Corporate Officer/Principal | 2003-12-31 |
Training of John Trizzino
| Long Island University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| HENRY SCHEIN, INC. | Distribution Services |
| NOVAVAX, INC. | Health Technology |
| IMV INC. | Health Technology |
| Private companies | 3 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
- Stock Market
- Insiders
- John Trizzino
